HomeNewsMedically Home Raises $110 Million; Baxter, Cardinal, and Global Health Become Board...

Medically Home Raises $110 Million; Baxter, Cardinal, and Global Health Become Board Members

From an individual, as well as a societal standpoint, it’s important for us to stay growth-oriented in every possible situation. There are many incentives driving this charge, but the one that binds them all together is just the straightforward idea of having a more wholesome living experience. Now, over the years, we have attempted to achieve the said experience in some really different ways. Each of these attempts successfully made some noise here and there, except none could do it so sensationally like technology. When you look at technology’s stature today, it’s easy to assume the whole scenario materialized right out of the gate. However, in reality, the creation had to work rather tirelessly for literally every single milestone. Talk about technology’s milestones, they would go on to appear throughout the spectrum. One notable appearance, however, came within the medical sector. Using the creation’s generational capabilities, our global healthcare system was able to establish an image, which defied everyone’s longstanding negative perception of it, but there is still a lot more to come. In fact, a recently concluded funding round validates that belief big time.

Medically Home, a Boston based medtech company, has officially raised $110 million, as it looks to further expand its ‘hospital at home’ care model. The funding was provided by Baxter International, Cardinal Health, and Global Health Response. Apart from agreed financial remuneration, these companies can expect to have representation on Medically Home’s executive board. Interestingly enough, they join two other medical industry’s giants, Mayo Clinic and Kaiser Permanente on the table. While Medically Home has been slowly trudging towards growth for some time now, the traction it’s getting lately should barely surprise anyone. With pandemic causing major wreak-havoc across the world, being able to treat a patient in the comfortable surroundings of their home has become an increasingly attractive prospect. Medically Home, in turn, helps in realizing that intention through its dedicated remote care platform, which is said to be well-equipped for treating higher-acuity diseases such as Covid 19, heart failure, and cancer etc.

“The accelerating decentralization of high acuity care from hospitals and other institutional sites to an ever-increasing number of patient’s homes enabled by Medically Home, validates the importance of an ecosystem of health care partners working together on behalf of patients and the clinicians that care for them across the country,” said Rami Karjian, Chief Executive Officer of Medically Home.

Having already served over 7,000 patients, Medically Home will now hope to use the latest financial infusion for catering an aggressively burgeoning requirement related to “flexible hospital capacity, evolving patient preferences and continued shift toward hospital care at home as hospital capacity pressures mount.”

 

Must Read

Related News